Technical Problems, Regulatory and Market Challenges in Bringing Herbal Drug into Mainstream of Modern Medicinal Practices

被引:0
作者
Prabhakar, P. [1 ]
Mamoni, Banerjee [1 ]
机构
[1] Indian Inst Technol Kharagpur, Biores Lab, Rajendra Mishra Sch Engn Entrepreneurship, Kharagpur 721302, W Bengal, India
来源
RESEARCH JOURNAL OF BIOTECHNOLOGY | 2021年 / 16卷 / 03期
关键词
Herbal drugs; phytochemicals; side-effects; formulation; drug market; regulatory; L. FIXED OIL; OCIMUM-SANCTUM; ALOE-VERA; ALZHEIMERS-DISEASE; CURCUMA-LONGA; PLANT; APOPTOSIS; BLOOD; NEEM; FLAVONOIDS;
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Awareness of people towards potentiality and lethal effect of modern and synthetic drugs has increased the interest towards herbal drugs. Herbal drugs have always proven their effectiveness in the treatment of severe diseases from the period of ancient civilizations. People believe in herbal drugs as a primary remedy for ailments instead of synthetic drugs. In recent years, the revival of herbal drugs has been observed due to lack of efficient modern therapies, issue of chronic diseases, side effect of chemical drugs, the resistance of microbes against a number of synthetic drugs and a big investment in drug discovery and development. In spite of huge benefit in healing diseases and less side-effect, herbal medicines are not key players in the current medical practices on a wide range as compared to allopathic medicines. In this review, we have highlighted and discussed the problems in herbal formulation development, regulatory and commercialization of herbal drugs and suggested possible solutions to bring up them into the mainstream of contemporary medical practices and healthcare.
引用
收藏
页码:212 / 222
页数:11
相关论文
共 126 条
[1]   Randomized phase III study of exatecan and gemcitabine compared with gemcitabine alone in untreated advanced pancreatic cancer [J].
Abou-Alfa, Ghassan K. ;
Letourneau, Richard ;
Harker, Graydon ;
Modiano, Manuel ;
Hurwitz, Herbert ;
Tchekmedyian, Nerses Simon ;
Feit, Kevie ;
Ackerman, Judie ;
De Jager, Robert L. ;
Eckhardt, S. Gail ;
O'Reilly, Eileen M. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) :4441-4447
[2]  
Agarwal V., 2015, J MED PLANTS STUD, V3, P74
[3]  
Agrawal A, 2010, ASIAN PAC J CANCER P, V11, P1311
[4]  
Ajmera Neha, 2013, J Indian Soc Periodontol, V17, P435, DOI 10.4103/0972-124X.118312
[5]   α-amylase inhibitory activity of some Malaysian plants used to treat diabetes;: with particular reference to Phyllanthus amarus [J].
Ali, Hasenah ;
Houghton, P. J. ;
Soumyanath, Amala .
JOURNAL OF ETHNOPHARMACOLOGY, 2006, 107 (03) :449-455
[6]  
[Anonymous], 1999, Paediatr Child Health, V4, P536
[7]  
[Anonymous], 2019, EC TIMES, P1
[8]  
[Anonymous], 2018, HERBAL MED MARKET RE, P1
[9]  
[Anonymous], 2015, J ORAL RES REV
[10]  
Ansari AS, 2017, J PHARMACOL TOX MET, V12, P57